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Concentrated growth factors (CGF) represents the novel generation of solid plate-
let concentrate preparations (1-2). These 100% autologous preparations, obtained 
from a venous blood sample, not only enhance tissue healing but also improve the 
clinical outcomes of various surgical procedures, reducing complications like pain, 
inflammation and morbidity (3). Considering the few data on CGF morphology 
and its biological properties, the aim of this study was to analyse the CGF structure 
(blood cell localization and fibrin matrix architecture) and the in vitro cumulative 
release of seven growth factors (PDGF-AB, VEGF, TNF-α, TGF-β1, IGF-I, BDNF and 
BMP-2). CGF was obtained from volunteer donors using a specific protocol of cen-
trifugation. Blood cell localization and fibrin architecture were evaluated after prop-
erly staining and immunostaining protocols. The kinetics of the growth factor release 
were performed by incubation of the CGF in a free growth factors cell medium, at 
37°C for 5 hours, 1, 3, 6, 7 and 8 days. After each incubation period, the medium 
was collected, centrifuged and stored at −80 °C until analysis. The total quantity of 
growth factors was checked using ELISA kits. After venous blood centrifugation, the 
CGF obtained consisted in three parts: the upper white part (PPP), the lower red part 
(RBC) and the middle “buffy coat” part (interface between white and red part). The 
results showed that platelets and leukocytes were localized in the buffy coat, where-
as the erythrocytes were present only in the red part of CGF. Moreover, in the white 
part, the fibrin network and architecture changed moving far from the buffy coat 
becoming less compact. The in vitro cumulative release of growth factors revealed 
that each of them had a specific kinetic. Considering the mean value obtained for 
each time point from all volunteers, PDGF-AB, TGF-β1 and IGF-1 had a constant 
kinetic release, reaching the maximum accumulation at day 3rd and 6th respectively; 
VEGF and BMP-2 had a slow kinetic release, reaching the maximum accumulation at 
day 8th; TNF-α and BDNF had a fast kinetic release, reaching the maximum accumu-
lation at day 1st and 3rd respectively. These findings support the clinical use of CGF 
and will allow us to better understand and improve the clinical outcomes.
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